Announcements Trials
Browse Landscape

Phase

Phase 2 4

Status

Terminated 4Completed 3Withdrawn 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Neoplasm Metastasis 1Granulosa Cell Tumor 1

Interventions

Cyclophosphamide 166Docetaxel 154Bevacizumab 153Carboplatin 148Gemcitabine 146Cisplatin 146pembrolizumab 142Radiotherapy 135Paclitaxel 132Capecitabine 122Rituximab 115Oxaliplatin 104Fluorouracil 103Nivolumab 94Irinotecan 85Doxorubicin 85Pemetrexed 83Leucovorin 82Dexamethasone 82fludarabine 74fludarabine phosphate 72Bortezomib 69Etoposide 67Erlotinib Hydrochloride 66Cetuximab 65Methotrexate 58Trastuzumab 56Cytarabine 54Lenalidomide 50Everolimus 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Terminated × orteronel × Clear all
NCT01816048 2019-12-09

NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasis

University of Wisconsin, Madison

Phase 2 Terminated
8 enrolled 15 charts
Genitourinary

Prostatic Neoplasms

NCT02101684 2018-03-05

Greko II

Grupo EspaƱol de Tumores HuƩrfanos e Infrecuentes

Phase 2 Terminated
10 enrolled

Granulosa Cell Tumor, Neoplasm Metastasis

NCT01866423 2017-08-31

Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

University of Southern California

Phase 2 Terminated
4 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT03211052 2017-07-07

NEPTUNE

Queen Mary University of London

Phase 2 Terminated
16 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔